3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
33
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma
19
Myelodysplastic Syndromes
16
Hodgkin Disease
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
10
Leukemia, Myeloid, Acute
10
Lymphoma, Non-Hodgkin
8
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
7
Recurrence
6
Myeloproliferative Disorders
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Chronic-Phase
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
4
Neoplasms, Plasma Cell
4
Lymphoma, T-Cell, Cutaneous
4
Congenital Abnormalities
4
Burkitt Lymphoma
4
Anemia, Aplastic
4
Sezary Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic-Myeloproliferative Diseases
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Large-Cell, Immunoblastic
3
Interventions
HhAntag691
14
sonidegib
4
methyl 5-aminolevulinate
3
Photochemotherapy
3
Aminolevulinic Acid
3
tazarotene
2
cemiplimab
2
IPI-926
2
Drug Evaluation
2
1-phenyl-3,3-dimethyltriazene
2
silmitasertib
1
remetinostat
1
prednylidene
1
pembrolizumab
1
deltacortene
1
Tacrolimus
1
Risk Factors
1
Prednisone
1
Nivolumab
1
NVP-BKM120
1
Mohs Surgery
1
Mindfulness
1
Midazolam
1
Itraconazole
1
Ipilimumab
1
IFL protocol
1
Folfox protocol
1
Fluorouracil
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Basal Cell
×
Alemtuzumab
×
Clear all
No trials found.